Impaired IL-10 Receptor Signaling Leads to Inflammation Induced Exhaustion in Hematopoietic Stem Cells
Authors:
- William Lucas WadleyWWWilliam Lucas Wadley
- Helen HuangHHHelen Huang
- Hew Yeng LaiHLHew Yeng Lai
- Jianhong HeidmannJHJianhong Heidmann
- Jane ChenJCJane Chen
- Eli SoyferESEli Soyfer
- Kalei GuillermoKGKalei Guillermo
- Eshika AroraEAEshika Arora
- Lauren ChenLCLauren Chen
- Brianna HooverBHBrianna Hoover
- Angela FleischmanAFAngela Fleischman
Preprint
Abstract
Hematopoietic stem cells require tight regulation to rapidly initiate emergency hematopoiesis in response to pathogens, but chronic activation leads to proliferation induced exhaustion. Timely reentry into quiescence after inflammatory stimuli is essential for long term sustained HSC maintenance. We identify IL-10R signaling, an established negative feedback regulator in mature myeloid cells, as critical for returning HSCs to quiescence. IL-10R blockade prolongs HSC cycling and sustains activated transcriptional programs after acute inflammation. With chronic exposure, blockade increases cumulative divisions and accelerates aging hallmarks, including myeloid bias, loss of polarity, and functional defects, under conditions that do not otherwise exhaust HSCs when IL-10R signaling is intact. Jak2 V617F mutant HSCs resist the aging acceleration induced by blockade. Consistent with this resistance, IL-10R blocking antibody promotes Jak2 V617F clonal expansion and augments the myeloproliferative neoplasm phenotype. Together, these findings identify IL-10R signaling as a key coordinator of post inflammatory return to quiescence and suggest that modulating this axis could preserve HSCs and shape clonal hematopoiesis. Summary: Wadley et al. show that IL-10 receptor signaling restrains inflammation-induced hematopoietic stem cell cycling and exhaustion; its blockade prolongs cycling, accelerates aging-related decline, and selectively favors Jak2 V617F mutant HSCs, establishing IL-10 signaling as a critical regulator of inflammatory HSC exhaustion and malignant clonal evolution.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK136069)
- National Cancer Institute (R37CA271172)
- National Heart Lung and Blood Institute (F31HL176174)
- University of California Irvine Institute of Immunology (T32AI0602573)
This publication has 35 references indexed in Scilit:
- Analysis of cortical cell polarity by imaging flow cytometryJournal of Cellular Biochemistry, 2023
- Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasmExperimental Hematology, 2021
- PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyCell Stem Cell, 2018
- Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative ConditionsCell Stem Cell, 2015
- The Hallmarks of AgingCell, 2013
- Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and RejuvenationCell Stem Cell, 2012
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor CellsCancer Cell, 2010
- Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and RepairCell, 2008
- Mouse hematopoietic stem cell identification and analysisCytometry Part A, 2008
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993